About Us
We support families affected by SCN8A by connecting families, researchers, clinicians, and partners to advance understanding and quality of life. Through DEEP and the Inchstone Project, we provide education, shared tools, and develop outcome measures that enable individuals with the most severe DEEs, including many with SCN8A, to participate in clinical research and trials.
Help shape the future of Decoding Developmental Epilepsies
Leadership Team
Gabi Conecker, MPH
Gabi hold a Masters in Public Health (MPH) and is the mother of Elliott, who has SCN8A and severe epilepsy (DEE). Driven by a parent’s desire to fight for their child, Gabi has made a significant impact in the SCN8A and DEE communities.
Co-Founder & CEO
JayEtta Hecker
JayEtta is a national advocate for families affected by rare and catastrophic epilepsies, with a focus on SCN8A and DEEs. Her work centers on building collaboration across families, researchers, clinicians, and industry to advance inclusive research and meaningful progress.
Co-Founder & Board Chair
Chief Operating OfficerKelly Muzyczka, PhD
Kelly Muzyczka is an applied social scientist with over ten years of experience leading collaborative research and program design efforts. Her work emphasizes equity, accessibility, and practical solutions that improve how systems work for families and communities.
Program Director & Lead ScientistGabby Sarlo, PhD
Gabby Sarlo is a clinical neuroscientist with seven years of experience in pediatric epilepsy, contributing through research, scientific program leadership, and science policy engagement. She is committed to translating complex science into clear, accessible information for researchers, clinicians, and families.
Board of Directors
Brian Pfister, PhD, MBA
Global Medical Affairs ExpertBrian is a pharmaceutical and biotechnology executive with nearly 30 years of experience in epilepsy and rare neurological disorders. His work is shaped by both industry leadership and his experience as a parent of a child with epilepsy.
Anne Thompson Heller, PhD, LMFT
Anne holds a PhD in human development and family sciences and has worked in research, clinical care, and policy focused on health and wellbeing. She is also the mother of a child with DEE, bringing lived experience to her commitment to supporting families.
Juliane Mills is a rare disease clinical and therapeutic strategy leader with more than 20 years of experience across research and global drug development. Her work focuses on building strong partnerships between patient advocacy groups and industry to advance patient-centered clinical research in complex and underserved conditions.
Therapeutic Strategy, Rare DiseaseJuliane Mills, MS, MPH
Ariel Gibbons, MEd
Educator and AdvocateAriel is an educator with a deeply personal connection to SCN8A and is dedicated to supporting families with SCN8A and DEEs. Her work focuses on strategic communications and board advocacy.
Christopher Breder, MD, PhD
Michael Halpern is a science and technology policy leader with more than 20 years of experience advancing mission-driven programs across healthcare, government, and advocacy organizations. His work focuses on strategic communications, movement building, and integrating scientific evidence into effective public policy.
Policy development & strategic commsMichael Halpern
Inna Hughes, MD, PhD